BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Clinical Outcome
5 results:

  • 1. A seven-gene CpG-island methylation panel predicts breast cancer progression.
    Li Y; Melnikov AA; Levenson V; Guerra E; Simeone P; Alberti S; Deng Y
    BMC Cancer; 2015 May; 15():417. PubMed ID: 25986046
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.
    Santarpia L; Iwamoto T; Di Leo A; Hayashi N; Bottai G; Stampfer M; André F; Turner NC; Symmans WF; Hortobágyi GN; Pusztai L; Bianchini G
    Oncologist; 2013; 18(10):1063-73. PubMed ID: 24072219
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathological and molecular characterization of colorectal micropapillary carcinoma.
    Verdú M; Román R; Calvo M; Rodón N; García B; González M; Vidal A; Puig X
    Mod Pathol; 2011 May; 24(5):729-38. PubMed ID: 21336262
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Hereditary ovarian cancer.
    Prat J; Ribé A; Gallardo A
    Hum Pathol; 2005 Aug; 36(8):861-70. PubMed ID: 16112002
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hereditary risk of women's cancers.
    Frank TS; Critchfield GC
    Best Pract Res Clin Obstet Gynaecol; 2002 Oct; 16(5):703-13. PubMed ID: 12475549
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.